Regulatory T Cells

Regulatory T Cells (Tregs) are a specialized subset of T lymphocytes crucial for maintaining immune system balance and preventing excessive immune responses. Identified by the expression of the transcription factor Foxp3, Tregs play a pivotal role in immune tolerance and the prevention of autoimmune diseases. These cells suppress the activity of other immune cells, such as effector T cells, B cells, and antigen-presenting cells, to avoid unwarranted immune reactions against self-antigens. Tregs exert their suppressive function through various mechanisms, including the secretion of immunosuppressive cytokines like interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β). Dysregulation or dysfunction of Tregs can lead to autoimmune disorders, allergies, and inflammatory diseases. Conversely, harnessing the immunosuppressive properties of Tregs is explored in therapeutic approaches to control immune responses, such as in transplantation and autoimmune disease treatments. Understanding the intricate mechanisms that govern the functions of regulatory T cells is vital for advancing immunotherapy strategies, aiming to modulate immune responses for therapeutic benefits while preserving immune homeostasis. Ongoing research continues to unravel the complexities of Treg biology, offering potential insights into novel treatments for immune-related disorders.